Maybe this should be under a new thread but I will have to say that a cell product that deals with inflammatory conditions is pretty powerful, whether or not it is made in America:
https://www.theage.com.au/national/the-silent-killer-why-medical-research-is-fired-up-about-inflammation-20211126-p59cdw.html
The above was actually the best story of the (Sydney Morning Herald companion) Good Weekend magazine of 2022.
The interesting thing is, most people are not aware that inflammation is just a topic that researchers are starting to know more of, as opposed to something that people already know a lot about. In this sense, it is pioneering science if you can come up with product platforms that address multiple inflammatory conditions in multiple organs. Despite what some of us will lament as a bad choice for a first indication, kids’ SR aGVHD approval will open many doors I believe.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17526
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.06 |
Change
-0.030(2.75%) |
Mkt cap ! $1.267B |
Open | High | Low | Value | Volume |
$1.10 | $1.13 | $1.05 | $5.560M | 5.097M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 145674 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.06 | 28826 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 41724 | 1.060 |
15 | 144325 | 1.055 |
42 | 255409 | 1.050 |
17 | 136289 | 1.045 |
13 | 162318 | 1.040 |
Price($) | Vol. | No. |
---|---|---|
1.065 | 59873 | 14 |
1.070 | 61437 | 11 |
1.075 | 131223 | 11 |
1.080 | 73897 | 6 |
1.085 | 48229 | 5 |
Last trade - 13.34pm 10/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.06 |
  |
Change
-0.030 ( 3.29 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.13 | $1.05 | 1233327 | ||
Last updated 13.53pm 10/05/2024 ? |
Featured News
MSB (ASX) Chart |